Search Results
262 Results for 'Therapeutics & Vaccines'
PAGE 11 OF 11
Technology
Multilayer Tissue Regeneration System
Under physiological conditions, bone tissue regeneration involves a complex interplay of multiple biologically active molecules and stem cells. The molecules are often presented sequentially in cascad...
Learn More
Learn More
William Murphy | P05256US
Technology
Method and System for Delivering Nucleic Acid into a Target Cell
The normal growth and development of tissue requires a complex interplay of multiple signals from multiple genes in well-defined locations, leading to the controlled differentiation of precursor cells...
Learn More
Learn More
William Murphy, Siyoung Choi | P06064US
Technology
Reverse Genetics Approach for Generating Ebola Virus and Other Filoviruses from Cloned DNA
Ebola virus, a negative strand RNA virus in the family Filoviridae, is among the most lethal human pathogens. Efforts to develop treatments for Ebola infections have been hampered by a lack of effecti...
Learn More
Learn More
Yoshihiro Kawaoka, Gabriele Neumann, Luke Jasenosky | P01214US
Technology
Nanoparticles That Target Dendritic Cells
Dendritic cells play an important role in the process of initiating immune response. They are present in small quantities in tissues, such as skin and lung, that are in contact with the external envir...
Learn More
Learn More
Ferencz Denes, Zsuzsanna Fabry, Matyas Sandor | P07026US
Technology
Using Anti-Estrogens to Treat Cervical or Vaginal Cancer and Dysplasia
More than 11,000 American women were diagnosed with cervical cancer in 2008. Treatment of this disease, which consists of surgical, chemotherapeutic and radiation therapies, costs an estimated $1.7 bi...
Learn More
Learn More
Paul Lambert, Sang Hyuk Chung | P09292US03
Technology
Stable Collagen Mimics
Collagen, the most abundant protein in vertebrates, provides structure for tissues and plays a key role in wound healing. In connective tissue, individual collagen molecules are wound together in tigh...
Learn More
Learn More
Ronald Raines, Matthew Shoulders, Jonathan Hodges | P06406US
Technology
Methods and Compositions for Treating Prostate Cancer with DNA Vaccines
Prostate cancer is the second most common form of cancer among North American men. Current therapies for prostate cancer involve either removing the entire gland or treating it with radiation; however...
Learn More
Learn More
Douglas McNeel | P02376US
Technology
Novel Candidates for an Improved Tuberculosis Vaccine
Approximately one-third of the world’s population is infected with the bacterium Mycobacterium tuberculosis, the causative agent of tuberculosis (TB). Five to 10 percent of non-immunocompr...
Learn More
Learn More
Adel Talaat, Bassam Abomoelak, Sarah Ward | P09203US02
Technology
Novel Antibacterial Small Molecules
As the incidence of antibiotic resistance among bacteria continues to rise, the discovery of new antibacterial compounds has become increasingly critical to fighting infectious disease. According to t...
Learn More
Learn More
Helen Blackwell, Matthew Bowman, Joseph Stringer | P07517US
Technology
Novel Antiviral Peptides Against Influenza Virus
Influenza viruses cause morbidity and mortality worldwide. In the United States, influenza is responsible for approximately 200,000 hospitalizations and 36,000 deaths each year.
Two classes of antiv...
Learn More
Learn More
Stacey Schultz-Cherry, Curtis Brandt, Jeremy Jones | P08294US
Technology
Strong, Stable, Semisynthetic Collagen Mimic for Wound Healing, Artificial Skin, Sutures and Leather
Collagen is the most abundant protein in vertebrates. It serves as the fundamental structural protein for vertebrate tissues and is critically important in wound healing. Many diseases, including arth...
Learn More
Learn More
Ronald Raines, Frank Kotch | P08274US
Technology
Tat-Utrophin as a Protein Therapy for Muscular Dystrophies
No effective therapy currently exists for the most common and severe form of muscular dystrophy disease, Duchenne Muscular Dystrophy (DMD). This disease, which is characterized by the weakening of vol...
Learn More
Learn More
James Ervasti, Kevin Sonnemann | P06414US